Management

John-Michel T. Huss, MBA
President and Chief Executive Officer
John-Michel T. Huss brings more than 20 years of global experience in the pharmaceutical industry to Theratechnologies. He began his career at Merck & Co., occupying various sales and marketing positions in the United States and in Europe.  In 1996, he accepted an International Product Manager position at the headquarters of F. Hoffman-La Roche, in Basel.  Mr. Huss joined Sanofi-Synthelabo GmbH in 1999, where he held positions of increasing responsibility in Germany and in Canada.  He was appointed General Manager of the Swiss subsidiary at sanofi-aventis in 2007 (Sanofi-Synthelabo merged with Aventis in 2004), and in 2009 was promoted to the position of Chief of Staff, Office of the CEO, in Paris. Mr. Huss holds an International MBA from the University of South Carolina in Columbia (USA).
   
Luc Tanguay, M.Sc., CFA
Senior Executive Vice President and Chief Financial Officer
Luc Tanguay has been active in the biotechnology industry for over 15 years. As a member of senior management at Theratechnologies since 1996, he has contributed to the Company’s growth by facilitating access to public and private capital funding. A member of the Board of Directors since 1993, he has held various management posts since joining the Company. Prior to joining Theratechnologies, Mr. Tanguay had a successful career in investment banking at Lévesque Beaubien (now National Bank Financial) where he helped several organizations establish themselves as public companies.
   
Marie-Noël Colussi, CA
Vice President, Finance
Marie-Noël Colussi is a graduate of Université du Québec à Montréal in business administration. Prior to joining Theratechnologies, Ms. Colussi worked for eight years with KPMG, a major accounting firm. Ms. Colussi has acquired sound experience in accounting, auditing, control and taxation, particularly in R&D. She joined Theratechnologies in March 1997, and prior to her appointment as Vice President, Finance in February 2002, she successively held the positions of Director, Accounting and Internal Control as well as Controller.
   
Jocelyn Lafond, LL.B., LL.M.
Vice President, Legal Affairs, and Corporate Secretary
Mr. Lafond has 15 years of experience in the fields of corporate and securities laws.  Mr. Lafond holds a law degree from Université Laval and a Masters Degree in Law from the University of Toronto. He has been a member of the Barreau du Québec since 1992. Prior to joining Theratechnologies, Mr. Lafond was a partner with the international law firm of Fasken Martineau DuMoulin, LLP.
   
Julie Mac Allister, MBA
Vice President, Human Resources
With close to 20 years of experience in Human Resource Management in the pharmaceutical and telecommunication industries, Ms. Julie Mac Allister is well known for her expertise in organizational development, talent management and organizational change. Prior to joining Theratechnologies in 2011, she was responsible for organizational development at Sanofi-aventis and Sanofi-pasteur (Montreal & Toronto) which included employee commitment, leadership development, change management, performance and talent management. Ms. Mac Allister holds a Bachelor's degree in Human Resources Management from HEC Montréal, and an MBA from the University of Sherbrooke.
   
Christian Marsolais, Ph. D.
Vice President, Scientific Affairs and Alliances
Dr. Christian Marsolais has over 15 years of experience in clinical research for large pharmaceutical companies, such as Sandoz Canada and BioChem Therapeutics. Before joining Theratechnologies in 2007, Dr. Marsolais held various positions at Pfizer Global Pharmaceuticals, where he was appointed Director of Medical Affairs, Therapeutic Areas, in 2004.  In this position, Dr. Marsolais was responsible for the clinical program and the development of scientific initiatives , as well as the integration of the Scientific Affairs and Clinical Research for the Oncology and HIV Franchise. Dr. Marsolais holds a Ph.D. in biochemistry from the Université de Montréal.
   
Pierre Perazzelli, B.Sc.
Vice President, Pharmaceutical Development
A graduate of Université Laval, Pierre Perazzelli has more than 20 years of experience in the pharmaceutical manufacturing industry. Throughout his career, he has held various positions in large pharmaceutical companies, such as Bristol Myers Squibb and Abbott Laboratories. He was Director of the LAB Laboratory, a research centre specializing in pharmaceutical formulation. He is also experienced in the production of generic drugs. Mr. Perazzelli joined Theratechnologies in May 2000.
   
Krishna Peri, Ph.D.
Vice President, Research
Co-inventor of ExoPep™ technology and a founder of Pharma-G, Dr. Krishna Peri holds a Ph.D. in biochemistry from University of Saskatchewan, Canada. He pursued post-doctoral research in cancer as an NCI fellow at McGill University and at Ste. Justine Hospital Research Center. After the acquisition of Pharma-G by Theratechnologies in 2000, he served as Director of Discovery Research, and was appointed subsequently as Vice-President, Research, in June 2004.